WCN24-968 COMPARISON OF ESTIMATED AND MEASURED GFR IN INDIAN CIRRHOTIC PATIENTS:- A CASE SERIES

WCN24-968 COMPARISON OF ESTIMATED AND MEASURED GFR IN INDIAN CIRRHOTIC PATIENTS:- A CASE SERIES

Saved in:

Bibliographic Details
Main Authors:	Smita Divyaveer, Madhuri Kashyap, Kushal Kekan, Madhumita Premkumar, Kanchan Prajapati, Arka de, Anish Bhattacharya, Sarika Sharma Prashar, komalpreet Kaur, Ashok Kumar Yadav, Ajay Kumar Duseja, Nusrat Safiq, Harbir Singh Kohli
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924002699
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-3835 WHICH GFR FORMULA IS MOST ACCURATE IN INDIAN CIRRHOTIC POPULATION?
by: Smita Divyaveer, et al.
Published: (2025-02-01)

WCN24-1597 A PROSPECTIVE STUDY TO ANALYSE THE ACCURACY OF ESTIMATED GFR EQUATIONS AS COMPARED TO MEASURED GFR BY IOHEXOL CLEARANCE IN PATIENTS WITH LIVER CIRRHOSIS
by: Smita Divyaveer, et al.
Published: (2024-04-01)

WCN24-1579 TO COMPARE ACCURACY OF SERUM VS. URINE BIOMARKERS IN PREDICTING AKI AND MAJOR ADVERSE KIDNEY EVENTS AT DAY 30 IN CRITICALLY ILL CIRRHOTIC PATIENTS
by: Madhuri Kashyap, et al.
Published: (2024-04-01)

WCN25-1678 HIGH DOSE ERYTHROPOIETIN VERSUS DESIDUSTAT FOR TREATMENT OF ANEMIA IN PATIENTS OF CHRONIC KIDNEY DISEASE HAVING INADEQUATE RESPONSE TO WEIGHT BASED ERYTHROPOIETIN DOSE: PROSPECTIVE OBSERVATIONAL STUDY
by: Smita Divyaveer, et al.
Published: (2025-02-01)

WCN24-1172 GENDER DISPARITY AMONG CHRONIC KIDNEY DISEASE PATIENTS IN INDIA
by: Madhuri Kashyap, et al.
Published: (2024-04-01)

WCN24-1274 THE EFFECT OF LACTOFERRIN ON HEMOGLOBIN, ERYTHROFERRONE AND HEPCIDIN LEVELS IN CHRONIC KIDNEY DISEASE
by: Kushal Kekan, et al.
Published: (2024-04-01)

WCN24-668 ROLE OF COAGULATION FACTORS IN BLEEDING AND THROMBOTIC EVENTS IN CKD AND THEIR CORRELATION WITH CONVENTIONAL AND SONOCLOT PARAMETERS IN HAEMODIALYSIS PATIENTS
by: Smita Divyaveer, et al.
Published: (2024-04-01)

WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients
by: Kushal Kekan, et al.
Published: (2024-04-01)

WCN24-1323 TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA
by: Smita Divyaveer, et al.
Published: (2024-04-01)

WCN25-3605 Transplant immunosuppressant: a double edged sword in a kidney transplant patient
by: Madhuri Kashyap, et al.
Published: (2025-02-01)

Frequency of Vitamin D Deficiency in Cirrhotic Versus Non-Cirrhotic Liver Disease Patients
by: Ali Haroon, et al.
Published: (2024-09-01)

Post COVID Condition and Long‐Term COVID‐19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study
by: Prerna Sharma, et al.
Published: (2025-03-01)

WCN25-4036 Improved Outcomes with an Additional Rituximab Dose in Primary Membranous Nephropathy
by: Vinod Kumar, et al.
Published: (2025-02-01)

Cirrhotic cardiomyopathy
by: S. N. Mammayev, et al.
Published: (2010-06-01)

Comparing Cystatin C Estimated GFR With Creatinine Estimated GFR in Acute Kidney Injury Recovery
by: Kerry L. Horne, et al.
Published: (2025-08-01)

Mechanical Properties of Arecanut and GFR Hybrid Polypropylene Composites
by: Yarrapragada K. S. S. Rao, et al.
Published: (2022-01-01)

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes
by: Haihui Li, et al.
Published: (2024-10-01)

Colorectal Surgery in Cirrhotic Patients
by: Jacqueline Paolino, et al.
Published: (2014-01-01)

Feasibility of replacing 99mTc‐DTPA GFR measurements with eGFR from cystatin C in individuals with spinal cord injuries
by: Tatiana Kristensen, et al.
Published: (2025-05-01)

The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse Outcomes
by: Yumeng Wen, et al.
Published: (2025-06-01)

Superimposed pleural infection in cirrhotic chylothorax
by: Ken Ka Pang Chan, et al.
Published: (2024-11-01)

Admission Serum Bicarbonate Predicts Adverse Clinical Outcomes in Hospitalized Cirrhotic Patients
by: Michael Schopis, et al.
Published: (2021-01-01)

Albuminuria is Your Guide to Assessing Future GFR Slope
by: Omar Al Dhaybi, et al.
Published: (2024-02-01)

WCN25-4122 Rituximab in Primary Membranous Nephropathy- three years outcome
by: Prabjot Kaur Johal, et al.
Published: (2025-02-01)

Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)

Cirrhotic cardiomyopathy: a subject that's always topical
by: Mona Boudabbous, et al.
Published: (2024-12-01)

Refractory Spontaneous Bacterial Empyema in Cirrhotic Patient
by: Erica Chow, et al.
Published: (2021-01-01)

Cirrhotic cardiomyopathy as a problem in liver transplantation
by: S.M. Chooklin, et al.
Published: (2025-03-01)

ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY
by: M. V. Chistyakova, et al.
Published: (2017-07-01)

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
by: Maria Anna Guardascione, et al.
Published: (2009-11-01)

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
by: Lucio Amitrano, et al.
Published: (2009-11-01)

Evaluation of serum Cystatin C as a predictor of eGFR in type 2 diabetic patients with nephropathy
by: Aqsa Fatima, et al.
Published: (2025-06-01)

Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD
by: Masayuki Yamanouchi, et al.
Published: (2025-07-01)

Walking versus running and GFR trajectory in healthy young adults.
by: Ronit Calderon-Margalit, et al.
Published: (2025-01-01)

eGFR slope as predictor of mortality in heart failure patients
by: Sofie Verstreken, et al.
Published: (2025-04-01)

Patients With Mild ADPKD by Kidney Imaging but Low Estimated GFR
by: Seung Heyck Lee, et al.
Published: (2025-06-01)

In Defense of Age-Based Estimated GFR Thresholds to Define CKD
by: Pierre Delanaye, et al.
Published: (2025-01-01)

WCN25-2464 PATIENT SUPPORTED CARE MODEL: FEASIBILITY STUDY OF A MOBILE APPLICATION-BASED TOOL TO EXPLORE DRUG COMPLIANCE IN CHRONIC KIDNEY DISEASE
by: Sanja Sameer Behera, et al.
Published: (2025-02-01)

WCN24-2366 PREVALENCE OF LOW- VALUE THERAPY AMONG CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE IN INDIA- A CROSS SECTIONAL STUDY
by: Gowri Shankar, et al.
Published: (2024-04-01)

Expression of CD34 in cirrhotic liver: Reliance to dedifferentiation
by: Gligorijević Jasmina, et al.
Published: (2010-01-01)